title: [Prophylactic effectiveness of a live recombinant influenza type A vaccine in immunizing children aged 3-14 years].
abstract: Children aged 3 to 14 were immunized with live recombinant influenza A vaccine; about 120,000 children were followed up for 6 months. Analysis of the morbidity (excepting ARVI and influenza) of the immunized and control groups permitted a conclusion about the safety of the preparation. The protective index of vaccine efficacy during influenza epidemic caused by A/Taiwan/1/86(H1N1) virus was 1.3 to 1.42. Live recombinant influenza vaccine is recommended for public health to be used for protection of children aged 3 to 14 from influenza.
authors.forename: L G
authors.initials: LG
authors.lastname: Rudenko
authors.forename: R I
authors.initials: RI
authors.lastname: Vasil'eva
authors.forename: A T
authors.initials: AT
authors.lastname: Ismagulov
authors.forename: V I
authors.initials: VI
authors.lastname: Karagodina
authors.forename: A N
authors.initials: AN
authors.lastname: Slepushkin
authors.forename: E M
authors.initials: EM
authors.lastname: Doroshenko
authors.forename: E M
authors.initials: EM
authors.lastname: Gudkova
authors.forename: A Kh
authors.initials: AKh
authors.lastname: Utegulova
authors.forename: E P
authors.initials: EP
authors.lastname: Grigor'eva
authors.forename: E I
authors.initials: EI
authors.lastname: Burtseva
authors.forename: A L
authors.initials: AL
authors.lastname: Beliaev
authors.forename: N I
authors.initials: NI
authors.lastname: Lonskaia
authors.forename: V P
authors.initials: VP
authors.lastname: Drinevskiĭ
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006801:Humans; D009980:Influenza A virus / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage / Q000592:standards*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000592:standards
chemical_list: D007252:Influenza Vaccines; D014614:Vaccines, Synthetic
vernacular_title: Profilakticheskaia éffektivnost' zhivoĭ grippoznoĭ rekombinantnoĭ vaktsiny tipa A pri immunizatsii deteĭ 3-14 let.